|
Advancing the Understanding of
Overactive Bladder and
Voiding Dysfunctions
|
Pfizer is proud to announce the 2010 OAB-LUTS Competitive
Grants Program for Young Investigators
Mission
-
Support research that improves our understanding of overactive bladder and
other lower urinary tract dysfunctions as well as the impact these conditions
have on individuals and society.
-
Support promising Young Investigators’ efforts to establish research programs.
As competition for research funding increases, the OAB-LUTS Program underscores
Pfizer’s commitment to support promising Young Investigators with an interest
in advancing knowledge in overactive bladder and voiding dysfunctions.
Background
In 2004, a competitive grants program was initiated at Pfizer with a focus on
improving the understanding of overactive bladder (OAB) and voiding
dysfunction. This program represents Pfizer’s continued commitment to
supporting research at academic institutions worldwide. Grant applications are
reviewed by an international Independent Peer Review Selection Committee. Since
the program’s inception, 36 basic science projects and 26 clinical studies have
been funded.
Aside from supporting good research initiatives, goals of this program are to
help junior faculty establish their research programs and to help fellowship
programs support their research year. In 2009, applications from Young
Investigators within 4 years of completing residency were judged separately and
were accorded special consideration. While the goal was for half of the grants
(5) to be awarded to Young Investigators, the quality of these grant proposals
was such that 6 of the 10 grants were awarded to Young Investigators.
Request for Proposals
Pfizer invites clinical and postgraduate (including masters level) fellows to
apply for the 2010 OAB-LUTS Competitive Grants Program for Young Investigators*
through submission of research proposals. The deadline for submission is
December 14, 2009.
*Young Investigators are investigators within 5 years of completing residency or
advanced degree (masters or doctoral). Faculty and department sponsorship will
be needed to support Applicants who are in residency, fellowship, or
postdoctoral positions.
Areas of Focus
Pfizer invites health care providers worldwide to submit proposals outlining
innovative and scientifically valid research projects focused on Advancing the
Understanding of Overactive Bladder and Voiding Dysfunctions. The
program will be accepting clinical or outcomes research projects, including
drug and non-drug studies. Basic science proposals will not be accepted this
funding cycle. Areas of particular interest for 2010 are:
-
Explore approaches to facilitate diagnosis and treatment of lower urinary tract
symptoms including OAB
-
Advance our understanding of patient decision-making in multimodal management
of lower urinary tract dysfunctions including behavioral interventions
-
Advance our understanding of the impact of OAB and other lower urinary tract
symptoms on patients, their families and society including economic
implications
-
Advance the ability to identify patient-specific therapies for the treatment of
OAB/LUTS
-
Advance the treatment of overactive bladder including special populations such
as long-term care, neurogenic bladder, diabetes, ethnic groups and continent
OAB patients
-
Advance the understanding of the role of bladder health education in prevention
and treatment of lower urinary tract dysfunction including OAB
To be considered for funding, any proposal involving drugs must be limited to
Pfizer products. Pfizer drugs and placebo will be supplied by Pfizer at
no cost.
Available Awards
It is anticipated that 10 awards will be granted in February 2010. Each award
will be for a maximum of $75,000 USD inclusive of overhead costs. All awards with be paid in US Dollars.
Projects should yield results that would merit submission as an abstract to a
scientific meeting, followed by publication in a peer-reviewed journal.
Questions
For questions or program inquiries, please contact Susan R. Grady, RN, APN, MSN,
at grants@oab-luts.com.
For technical support, please send an e-mail to IIR@pfizer.com or call IIR
Hotline in US: 877-IIR-5670 / 877-447-5670 (Mon– Fri 9:30am to 3:30 PM EST)
Outside the US, call: 203-316-9059
|